The Nevro Senza, as shown in a video on the company's website. Nevro’s stock is now up more than 20% from where it was late last week, after the Menlo Park, CA–based company said that the FDA has deemed the PMA for its spinal ...
Tags: spinal pain-killing device, Health
Handsome in South Manchester, UK, has received £250,000 from The North West Fund for Biomedical, managed by SPARK Impact. Handsome will use the capital to complete product development and clinical trial studies as well as achieve ...
Tags: spinal pain, Biomedical, clinical trial studies, healthcare